Ipsen (XTER:I7G) Interest Expense : €-38 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Ipsen Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ipsen's interest expense for the six months ended in Dec. 2023 was € -22 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-38 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ipsen's Operating Income for the six months ended in Dec. 2023 was € 265 Mil. Ipsen's Interest Expense for the six months ended in Dec. 2023 was € -22 Mil. Ipsen's Interest Coverage for the quarter that ended in Dec. 2023 was 11.85. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ipsen Interest Expense Historical Data

The historical data trend for Ipsen's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Interest Expense Chart

Ipsen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-30.80

-27.50

-23.70

-30.50

-37.70

Ipsen Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-11.70	-11.40	-19.10	-15.30	-22.40

Ipsen Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-38 Mil.

Ipsen (XTER:I7G) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ipsen's Interest Expense for the six months ended in Dec. 2023 was €-22 Mil. Its Operating Income for the six months ended in Dec. 2023 was €265 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was €270 Mil.

Ipsen's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	265.4	/	-22.4
	=	11.85

The higher the ratio, the stronger the company's financial strength is.

Ipsen (XTER:I7G) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (XTER:I7G) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

IPSEY:USA IPSEF:USA 0MH6:UK IPN:France I7G:Germany

Address

65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Ipsen (XTER:I7G) Headlines

No Headlines